|
週次 |
日期 |
單元主題 |
|
第2週 |
2/24 |
新春開始-暫停一次 |
|
第3週 |
3/3 |
Intrinsically active nanobody-modified polymeric micelles for tumor-targeted combination therapy (核心能力2,4,7) |
|
第4週 |
3/10 |
Glycol chitosan nanoparticles as specialized cancer therapeutic vehicles: Sequential delivery of doxorubicin and Bcl-2 siRNA (核心能力2,4,7) |
|
第5週 |
3/17 |
PET Imaging of Very Late Antigen-4 in Melanoma Comparison of 68Ga- and 64Cu-Labeled NODAGA and CB-TE1A1P-LLP2A Conjugates (核心能力2,4,7) |
|
第6週 |
3/24 |
Transferrin receptor-targeted theranostic gold nanoparticles for photosensitizer delivery in brain tumors.(核心能力2,4,7) |
|
第7週 |
3/31 |
tumor vasculature targeted photodynamic therapy for enhanced delivery of nanoparticles (核心能力2,4,7) |
|
第8週 |
4/7 |
Regorafenib inhibits growth, angiogenesis, and metastasis in a highly aggressive, orthotopic colon cancer model.(核心能力2,4,7) |
|
第9週 |
4/14 |
Ultrasound-guided delivery of microRNA loaded nanoparticles into cancer.(核心能力2,4,7) |
|
第10週 |
4/18 |
期中考-暫停一次 |
|
第11週 |
4/28 |
Apoferritin Modified Magnetic Particles as Doxorubicin Carriers for Anticancer Drug Delivery (核心能力2,4,7) |
|
第12週 |
5/5 |
Self-assembled glycol chitosan nanoparticles for disease-specific theranostics.(核心能力2,4,7) |
|
第13週 |
5/12 |
Self-assembled glycol chitosan nanoparticles for disease-specific theranostics.(核心能力2,4,7) |
|
第14週 |
5/19 |
The interaction of carbon nanotubes with an in vitro blood-brain barrier model and mouse brain in vivo (核心能力2,4,7) |
|
第15週 |
5/26 |
Preclinical evaluation of a novel CEA-targeting near-infrared fluorescent tracer delineating colorectal and pancreatic tumors(核心能力2,4,7) |
|
第16週 |
6/2 |
教授出席國際會議-暫停一次 |
|
第17週 |
6/9 |
Enrichment of CD133-expressing cells in rectal cancers treated with preoperative radiochemotherapy is an independent marker for metastasis and survival.(核心能力2,4,7) |
|
第18週 |
6/16 |
Tumor targeting profiling of hyaluronan-coated lipid based-nanoparticles(核心能力2,4,7) |
|
第19週 |
6/24 |
期末考-暫停一次 |